{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:55:06Z","timestamp":1762869306627,"version":"build-2065373602"},"reference-count":21,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T00:00:00Z","timestamp":1619568000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology, Transfusion and Cell Therapy"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.htct.2021.03.006","type":"journal-article","created":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T19:35:44Z","timestamp":1621366544000},"page":"465-471","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["The relevance of a bank with genotyped platelets donors"],"prefix":"10.1016","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6266-1264","authenticated-orcid":false,"given":"Nat\u00e1lia Bollini de Ara\u00fajo","family":"Barbagallo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thiago Henrique","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"Bastos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Giselda","family":"Aravechia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3784-6731","authenticated-orcid":false,"given":"Jose Mauro","family":"Kutner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5103-4970","authenticated-orcid":false,"given":"Carolina","family":"Bonet-Bub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9585","key":"10.1016\/j.htct.2021.03.006_bib0001","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0140-6736(07)61198-2","article-title":"Platelet transfusions","volume":"370","author":"Stroncek","year":"2007","journal-title":"Lancet [Internet]"},{"issue":"3","key":"10.1016\/j.htct.2021.03.006_bib0002","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.transci.2012.04.003","article-title":"Survey of current practice for monitoring and management of platelet refractoriness in Italy","volume":"47","author":"Quaglietta","year":"2012","journal-title":"Transfus Apher Sci [Internet]"},{"issue":"4","key":"10.1016\/j.htct.2021.03.006_bib0003","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1399-0039.2012.01852.x","article-title":"HLA alloimmunization against platelet transfusions: pathophysiology, significance, prevention and management","volume":"79","author":"Pavenski","year":"2012","journal-title":"Tissue Antigens [Internet]"},{"issue":"4","key":"10.1016\/j.htct.2021.03.006_bib0004","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1054\/blre.2001.0164","article-title":"Diagnosis and management of refractoriness to platelet transfusion","volume":"15","author":"Schiffer","year":"2001","journal-title":"Blood Rev [Internet]"},{"issue":"3","key":"10.1016\/j.htct.2021.03.006_bib0005","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/bjh.13597","article-title":"Platelet refractoriness - practical approaches and ongoing dilemmas in patient management","volume":"171","author":"Stanworth","year":"2015","journal-title":"Br J Haematol [Internet]"},{"issue":"10","key":"10.1016\/j.htct.2021.03.006_bib0006","doi-asserted-by":"crossref","first-page":"4106","DOI":"10.1182\/blood-2003-08-2724","article-title":"Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients","volume":"105","author":"Slichter","year":"2005","journal-title":"Blood [Internet]"},{"issue":"4","key":"10.1016\/j.htct.2021.03.006_bib0007","first-page":"252","article-title":"Platelet antibody detection by flow cytometry: an effective method to evaluate and give transfusional support in platelet refractoriness","volume":"35","author":"Bub","year":"2013","journal-title":"Rev Bras Hematol Hemoter [Internet]"},{"issue":"2","key":"10.1016\/j.htct.2021.03.006_bib0008","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0887-7963(00)80007-3","article-title":"The evaluation and management of platelet refractoriness and alloimmunization","volume":"14","author":"Delaflor-Weiss","year":"2000","journal-title":"Transfus Med Rev [Internet]"},{"key":"10.1016\/j.htct.2021.03.006_bib0009","doi-asserted-by":"crossref","DOI":"10.1002\/1096-8652(200008)64:4<251::AID-AJH3>3.0.CO;2-N","article-title":"Platelet transfusions: utilization and associated costs in a tertiary care hospital","author":"Meehan","year":"2000","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1016\/j.htct.2021.03.006_bib0010","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1182\/blood.V71.2.383.383","article-title":"Clinical factors influencing the efficacy of pooled platelet transfusions","volume":"71","author":"Bishop","year":"1988","journal-title":"Blood [Internet]"},{"issue":"1","key":"10.1016\/j.htct.2021.03.006_bib0011","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00277-017-3168-6","article-title":"Factors influencing platelet transfusion refractoriness in patients undergoing allogeneic hematopoietic stem cell transplantation","volume":"97","author":"Solves","year":"2018","journal-title":"Ann Hematol [Internet]"},{"issue":"1","key":"10.1016\/j.htct.2021.03.006_bib0012","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1590\/S1807-59322011000100007","article-title":"Identification of platelet refractoriness in oncohematologic patients","volume":"66","author":"Ferreira","year":"2011","journal-title":"Clinics [Internet]"},{"issue":"1","key":"10.1016\/j.htct.2021.03.006_bib0013","first-page":"189","article-title":"Estudo da refratariedade plaquet\u00e1ria em pacientes submetidos ao transplante de medula \u00f3ssea do dia 0 ao dia\u202f+\u202f50","volume":"25","author":"Paula","year":"2003","journal-title":"Rev bras hematol hemoter"},{"issue":"5","key":"10.1016\/j.htct.2021.03.006_bib0014","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.humimm.2020.02.005","article-title":"Diagnosis and treatment of immunological platelet refractoriness by histocompatibility","volume":"81","author":"Fagundes","year":"2020","journal-title":"Hum Immunol [Internet]"},{"key":"10.1016\/j.htct.2021.03.006_bib0015","doi-asserted-by":"crossref","DOI":"10.1046\/j.1365-2370.1999.00174.x","article-title":"Frequencies of platelet-specific alloantigen systems 1-5 in three distinct ethnic groups in Brazil","author":"Castro","year":"1999","journal-title":"Eur J Immunogenet"},{"key":"10.1016\/j.htct.2021.03.006_bib0016","article-title":"Prospective evaluation of platelet refractoriness in haematological patients in a single Brazilian institution","author":"Bub","year":"2020","journal-title":"ISBT Sci Ser"},{"key":"10.1016\/j.htct.2021.03.006_bib0017","doi-asserted-by":"crossref","DOI":"10.1111\/tme.12338","article-title":"The human platelet alloantigen profile in blood donors from Amazonas, Brazil","author":"Portela","year":"2016","journal-title":"Transfus Med"},{"key":"10.1016\/j.htct.2021.03.006_bib0018","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2141.2008.07189.x","article-title":"Platelet transfusion refractoriness","author":"Hod","year":"2008","journal-title":"Brit J Haematol"},{"key":"10.1016\/j.htct.2021.03.006_bib0019","doi-asserted-by":"crossref","DOI":"10.1111\/tme.12423","article-title":"Analysis of platelet-reactive alloantibodies and evaluation of cross-match-compatible platelets for the management of patients with transfusion refractoriness","author":"Wang","year":"2018","journal-title":"Transfus Med"},{"issue":"12","key":"10.1016\/j.htct.2021.03.006_bib0020","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1111\/trf.14316","article-title":"How do I \u2026 manage the platelet transfusion-refractory patient?","volume":"57","author":"Juskewitch","year":"2017","journal-title":"Transfusion [Internet]"},{"issue":"1","key":"10.1016\/j.htct.2021.03.006_bib0021","doi-asserted-by":"crossref","first-page":"274","DOI":"10.2119\/molmed.2015.00235","article-title":"Generation of HLA-universal iPSC-derived megakaryocytes and platelets for survival under refractoriness conditions","volume":"22","author":"B\u00f6rger","year":"2016","journal-title":"Mol Med [Internet]"}],"container-title":["Hematology, Transfusion and Cell Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137921000572?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137921000572?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:35:45Z","timestamp":1762868145000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2531137921000572"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S2531137921000572"],"URL":"https:\/\/doi.org\/10.1016\/j.htct.2021.03.006","relation":{},"ISSN":["2531-1379"],"issn-type":[{"type":"print","value":"2531-1379"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The relevance of a bank with genotyped platelets donors","name":"articletitle","label":"Article Title"},{"value":"Hematology, Transfusion and Cell Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.htct.2021.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Espa\u00f1a, S.L.U. on behalf of Associa\u00e7\u00e3o Brasileira de Hematologia, Hemoterapia e Terapia Celular.","name":"copyright","label":"Copyright"}]}}